WealthTrust Axiom’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-13,386
| Closed | -$100K | – | 255 |
|
|
2022
Q2 | $100K | Buy |
13,386
+2
| +0% | +$15 | 0.04% | 224 |
|
|
2022
Q1 | $125K | Hold |
13,384
| – | – | 0.04% | 241 |
|
|
2021
Q4 | $107K | Buy |
13,384
+1,000
| +8% | +$8K | 0.03% | 239 |
|
|
2021
Q3 | $120K | Sell |
12,384
-143
| -1% | -$1.39K | 0.04% | 231 |
|
|
2021
Q2 | $124K | Hold |
12,527
| – | – | 0.04% | 246 |
|
|
2021
Q1 | $144K | Buy |
12,527
+2,387
| +24% | +$27.4K | 0.05% | 225 |
|
|
2020
Q4 | $97K | Sell |
10,140
-5,044
| -33% | -$48.3K | 0.04% | 219 |
|
|
2020
Q3 | $136K | Hold |
15,184
| – | – | 0.06% | 186 |
|
|
2020
Q2 | $187K | Buy |
15,184
+1,500
| +11% | +$18.5K | 0.08% | 174 |
|
|
2020
Q1 | $122K | Buy |
13,684
+1,573
| +13% | +$14K | 0.06% | 166 |
|
|
2019
Q4 | $118K | Sell |
12,111
-938
| -7% | -$9.14K | 0.04% | 206 |
|
|
2019
Q3 | $89K | Hold |
13,049
| – | – | 0.03% | 217 |
|
|
2019
Q2 | $120K | Buy |
13,049
+1,700
| +15% | +$15.6K | 0.04% | 212 |
|
|
2019
Q1 | $177K | Sell |
11,349
-412
| -4% | -$6.43K | 0.06% | 207 |
|
|
2018
Q4 | $181K | Sell |
11,761
-145
| -1% | -$2.23K | 0.07% | 189 |
|
|
2018
Q3 | $256K | Hold |
11,906
| – | – | 0.09% | 181 |
|
|
2018
Q2 | $289K | Buy |
11,906
+150
| +1% | +$3.64K | 0.1% | 169 |
|
|
2018
Q1 | $200K | Sell |
11,756
-3,192
| -21% | -$54.3K | 0.07% | 205 |
|
|
2017
Q4 | $283K | Buy |
14,948
+3,440
| +30% | +$65.1K | 0.11% | 167 |
|
|
2017
Q3 | $202K | Buy |
11,508
+1,895
| +20% | +$33.3K | 0.08% | 194 |
|
|
2017
Q2 | $319K | Buy |
+9,613
| New | +$319K | 0.12% | 149 |
|